NASDAQ: SNES Richard Hantke: Hello everyone. My name is Richard Hantke with Zacks Small Cap Research , and welcome to another episode of our CEO Chat series. Today we've got SenesTech (NASDAQ: SNES), which is involved with rodent birth control solutions, which is kind of interesting. We'll get into that. Zacks has it under coverage with our analyst M. Marin. In her most recent report a few weeks
SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control and sustainable rodent population management, today announced that its Board of Directors has granted an inducement equity award to John Karabees in connection with his appointment as Executive Vice President, Sales.
SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control for managing animal pest populations, today announced that it will participate in a webcast presentation at the Lytham Partners 2026 Consumer & Technology Investor Summit, taking place virtually on Tuesday, August 18, 2026.
Detailed price information for Amazon.com Inc (AMZN-Q) from The Globe and Mail including charting and trades.
SenesTech, Inc. (NASDAQ: SNES), the leader in fertility control for managing animal pest populations and the only manufacturer of EPA-compliant Rodent Birth Control™ products, today announced financial results for the second quarter ended June 30, 2026.
SenesTech, Inc. (NASDAQ: SNES), a leader in rodent birth control solutions, today announced the introduction of assessment services designed to help B2B customers better understand the scope of rodent infestations and develop more effective long-term strategies. The new services further strengthen SenesTech's approach to helping customers achieve more effective rodent population management.
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.
SenesTech, Inc. (NASDAQ: SNES), the leader in rodent birth control solutions, today announced that its active online subscription customer base, comprising both direct-to-consumer ("DTC") and business-to-business ("B2B") customers, more than doubled during the second quarter of 2026 compared to the first quarter, reaching a record level. That expansion reinforces the Company's recurring revenue model while potentially increasing customer lifetime value and improving long-term revenue visibility.
SenesTech, Inc. (NASDAQ: SNES), a leader in fertility control solutions for managing rodent populations, will report financial results for its second quarter 2026, ended June 30, 2026, after the market close on Wednesday, August 5, 2026. The Company has scheduled a conference call that same day, Wednesday, August 5, 2026, at 5:00 pm ET, to review the results.
This is the newest page. Registered accounts read further back.